France Maternal Mental Health Market Size, Share, and COVID-19 Impact Analysis, By Disease indication (Postpartum Depression, Dysthymia, Pregnancy & Postpartum General Anxiety, Pregnancy & Postpartum OCD, Birth-Related PTSD, and Others), By Therapy (Interpersonal Psychotherapy (IPT), Cognitive Behavioral Therapy (CBT), Antidepressants, and Others), and France Maternal Mental Health Market Insights, Industry Trend, Forecasts to 2035

Industry: Healthcare

RELEASE DATE Jan 2026
REPORT ID SI17081
PAGES 240
REPORT FORMAT PathSoft

France Maternal Mental Health Market Insights Forecasts to 2035

  • The France Maternal Mental Health Market Size Was Estimated at USD 488.9 Million in 2024
  • The France Maternal Mental Health Market Size is Expected to Grow at a CAGR of Around 26.8% from 2025 to 2035
  • The France Maternal Mental Health Market Size is Expected to Reach USD 6,658.9 Million by 2035

 

Get more details on this report -

Request Free Sample PDF

 

According to a research report published by Spherical Insights & Consulting, The France Maternal Mental Health Market Size is anticipated to reach USD 6,658.9 Million by 2035, Growing at a CAGR of 26.8% from 2025 to 2035. The France maternal mental health market is driven by rising awareness of postpartum depression and anxiety, rising cases of maternal mental health issues, better access to doctors and therapy, and government support for programs that help new mothers.

 

Market Overview

The France maternal mental health market refers to the market offering services, therapies, and medications that help diagnose, prevent, and treat mental health problems, which could be stress, depression, anxiety, and other disorders arising due to pregnancy and childbirth. The market covers various interventions for postpartum depression, anxiety, stress, and other perinatal mental health disorders, provided through hospitals, clinics, therapy centers, and digital health platforms. Generally, this market is seeking to raise the mothers' physical and psychological health, facilitate healthy pregnancies, and increase the chances of a better development of the child. It is propelled by more awareness, rising cases, better access to care, digital therapy options, and government support.

 

Maternal mental health in France is becoming a major issue. According to national perinatal surveys, about 16.7% of women suffer from postpartum depression, and up to 27.6% experience symptoms of postpartum anxiety after delivery. That is approximately 1 out of 6 new mothers who have mental health problems during or after pregnancy, which indicates very significant needs for psychological support in the perinatal period that are not currently met. Besides, these disorders may hinder the mother-baby relationship, lead to developmental problems in the child, and affect the overall family environment. Thus, there is a very strong demand for specialized screening, psychotherapy, and mental health services that are specialized. The increasing recognition of the problems related to postpartum mental health and the development of medical facilities confirm the relevance of the maternal mental health market.

 

France has outlined the expansion of mental health support in line with the national health priorities; among them are the steps that directly or indirectly have an effect on maternal mental health. In 2025, the Government of France made a commitment of 200 million euros to transform mental health at a broad level with the aim of decentralizing healthcare, facilitating access to it, and professionalizing it through the training of professionals all over the country. This funding is the single largest yearly investment in mental health in the history of France and extends the coverage of services to those of perinatal and maternal mental health. Aside from that, to ensure a steady supply of mental health innovations and care, France is for the long haul through the PROPSY program, which has been granted €80 million for seven years under the France 2030 strategy. Thus, continued enhancement of innovation, research, and service provision will, among other things, contribute to achieving better maternal mental health outcomes.

 

Report Coverage

This research report categorizes the market for the France maternal mental health market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the France maternal mental health market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the France maternal mental health market.

 

France Maternal Mental Health Market Report Coverage

Report CoverageDetails
Base Year:2024
Market Size in 2024:USD 488.9 Million
Forecast Period:2025-2035
Forecast Period CAGR 2025-2035 :CAGR of 26.8%
2035 Value Projection:USD 6,658.9 Million
Historical Data for:2020-2023
No. of Pages:240
Tables, Charts & Figures:95
Segments covered:By Disease indication, By Therapy
Companies covered:: List of Key Companies, Pfizer Inc., Viatris Inc., GlaxoSmithKline (GSK), Mallinckrodt plc, Sage Therapeutics Inc., Bausch Health Companies Inc., Canopy Growth Corp., Therapy Mama, Maven Clinic, Happify Health, OpenUp, Doctolib, Others, and Key Players
Pitfalls & Challenges:COVID-19 Empact, Challenge, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The France maternal mental health market is driven by increasing awareness of postpartum depression and anxiety, a growing number of cases among new mothers, and easier access to mental health services. Beneficial government policies, reimbursement of psychological consultations, and the use of digital and tele-mental health solutions are contributing to the market development.

 

Restraining Factors

The France maternal mental health market is restrained by a few negative aspects, of which one is the stigma associated with mental health that makes some women less likely to go for help. Besides, there is a shortage of trained mental health professionals, especially in rural areas. Limited early screening, long waiting times for specialist care, and uneven access to services also hamper getting timely diagnosis and treatment.

 

Market Segmentation

 

The France maternal mental health market share is classified into disease indication and therapy.

 

  • The postpartum depression segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period

The France maternal mental health market is segmented by disease indication into postpartum depression, dysthymia, pregnancy & postpartum general anxiety, pregnancy & postpartum OCD, birth-related PTSD, and others. Among these, the postpartum depression segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The postpartum depression segment is growing because it has a high prevalence among new mothers in France, with strong awareness and improved screening after childbirth. Increased diagnosis rates, better access to therapy and medications, and government-supported mental health programs with reimbursed psychological consultations are driving higher treatment uptake and sustained market growth.

 

  • The interpersonal psychotherapy segment dominated the market in 2024 and is anticipated to grow at a substantial CAGR during the forecast period.

The France maternal mental health market is segmented by therapy into interpersonal psychotherapy (IPT), cognitive behavioral therapy (CBT), antidepressants, and others. Among these, the interpersonal psychotherapy segment dominated the market in 2024 and is anticipated to grow at a substantial CAGR during the forecast period. The interpersonal psychotherapy segment is growing because it is highly effective for perinatal and postpartum mental health conditions, especially postpartum depression. It focuses on relationship changes and role transitions after childbirth, is clinically recommended, is widely accepted by patients, and is increasingly covered under government-supported psychological care programs in France.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the France maternal mental health market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • Pfizer Inc.
  • Viatris Inc.
  • GlaxoSmithKline (GSK)
  • Mallinckrodt plc
  • Sage Therapeutics Inc.
  • Bausch Health Companies Inc.
  • Canopy Growth Corp.
  • Therapy Mama
  • Maven Clinic
  • Happify Health
  • OpenUp
  • Doctolib
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Recent Developments:

  • In January 2025, France expanded its Mon Soutien Psy mental health reform, increasing fully reimbursed psychological support sessions from eight to 12 per year and allowing patients to book without a GP referral, improving access to care for anxiety, depression, and related conditions affecting mothers and families.

 

  • In Apr 2025, the French government pledged €200 million in new funding toward Accelerated Mental Health Reform 2025, the largest single-year investment in mental health care aimed at expanding services, increasing access to psychological support, and improving mental health infrastructure efforts that also support maternal mental health care in France.

 

Market Segment

 

This study forecasts revenue at the France, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the France maternal mental health market based on the below-mentioned segments:

 

France Maternal Mental Health Market, By Disease Indication

  • Postpartum Depression
  • Dysthymia
  • Pregnancy & Postpartum General Anxiety
  • Pregnancy & Postpartum OCD
  • Birth-Related PTSD
  • Others

 

France Maternal Mental Health Market, By Therapy

  • Interpersonal Psychotherapy (IPT)
  • Cognitive Behavioral Therapy (CBT)
  • Antidepressants
  • Others

Frequently Asked Questions (FAQ)

  • 1.What is the France maternal mental health market size in 2024?
    The France maternal mental health market size was estimated at USD 488.9 million in 2024.
  • 2.What is the projected market size of the France maternal mental health market by 2035?
    The France maternal mental health market size is expected to reach USD 6,658.9 million by 2035.
  • 3.What is the CAGR of the France maternal mental health market?
    The France maternal mental health market size is expected to grow at a CAGR of around 26.8% from 2024 to 2035.
  • 4.What are the key growth drivers of the France maternal mental health market?
    The France maternal mental health market is driven by rising awareness of postpartum depression and anxiety, rising cases of maternal mental health issues, better access to doctors and therapy, and government support for programs that help new mothers.
  • 5.Which therapy segment dominated the market in 2024?
    The interpersonal psychotherapy (IPT) segment dominated the market in 2024.
  • 6.What segments are covered in the France maternal mental health market report?
    The France maternal mental health market is segmented on the basis of disease indication and therapy.
  • 7.Who are the key players in the France maternal mental health market?
    Key companies include Pfizer Inc., Viatris Inc., GlaxoSmithKline (GSK), Mallinckrodt plc, Sage Therapeutics Inc., Bausch Health Companies Inc., Canopy Growth Corp., Therapy Mama, Maven Clinic, Happify Health, OpenUp, Doctolib, and others.
  • 8.Who are the target audiences for this market report?
    The report targets market players, investors, end-users, government authorities, consulting and research firms, venture capitalists, and value-added resellers (VARs).

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies